Previous symbols: GLUD. Aliases: GDH, GDH1, hGDH1.
GLUD1 (glutamate dehydrogenase 1) is named by 2 disorder entries, including Congenital Isolated Hyperinsulinism; and Hyperinsulinemic Hypoglycemia.
ai-gene-review gives GLUD1's core molecular functions as ADP binding; and L-glutamate dehydrogenase [NAD(P)+] activity, in the mitochondrial matrix, acting in L-glutamate catabolic process; and tricarboxylic acid metabolic process.
Both entries record the variant origin as germline, and ClinGen rates the gene definitive for hyperinsulinism-hyperammonemia syndrome, a subtype of each entry. The gene sits on Glutamate Dehydrogenase Dysregulation (Amino-Acid-Driven HI) and Glutamate Dehydrogenase Amino-Acid Amplifier Activation. The disease is gain of function: the Congenital Isolated Hyperinsulinism node records glutamate dehydrogenase activity as increased, the same activity that is the gene's normal core function.
The KB and ai-gene-review share 0 GO process terms: the KB nodes are annotated with insulin-secretion processes, the review with glutamate catabolism.
Underlined values are claims re-computed from the knowledge base each time this page is built. The tables below are the source of truth.
ai-gene-review has this gene at status INITIALIZED; the description is shown only once the review is complete. Read the draft upstream.
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| Congenital Isolated Hyperinsulinism |
causative
germline
CLINGEN: definitive
|
mechanism: Glutamate Dehydrogenase Dysregulation (Amino-Acid-Driven HI)
subtype: HI/HA Syndrome
scoped to subtype: HI/HA Syndrome
|
| Hyperinsulinemic Hypoglycemia |
causative
germline
CLINGEN: definitive
|
mechanism: Glutamate Dehydrogenase Amino-Acid Amplifier Activation
subtype: HI/HA Syndrome
scoped to subtype: HI/HA Syndrome
|
An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.
| ClinGen disease | MOI | Classification | dismech entry |
|---|---|---|---|
| hyperinsulinism-hyperammonemia syndrome MONDO:0011717 | AD | Definitive 2020-11-13 |
Congenital Isolated Hyperinsulinism
causative
Hyperinsulinemic Hypoglycemia
causative
|
Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.